VACCINE FORMULATION INSTITUTE(CH)LTD

Forschungsprojekte

• Optimising a High Efficacy Plasmodium vivax Malaria Vaccine Plasmodium vivax is the most widespread human malaria with 2.5 billion people living at risk in South America…
• Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines BAXERNA 2.0 will establish a new vaccine development pipeline based on dramatically improved immunopeptidomic…
• A Vaccine Targeting Eradication of Malaria Malaria killed about 640 thousand people in 2020, largely young children in Africa. Rapid recent progress has…
• Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity Tuberculosis (TB) remains one of the most devastating infectious diseases worldwide, killing over 4,000 peopl…